Home / Drug shortages / Doxercalciferol Injection

Doxercalciferol Injection — FDA Drug Shortage

To Be Discontinued — Sanofi-Aventis U.S. LLC

The FDA lists a drug shortage record for Doxercalciferol Injection (injection) from Sanofi-Aventis U.S. LLC with status To Be Discontinued. The shortage was first posted on 12/10/2025.

Shortage Details

Status
To Be Discontinued
Company
Sanofi-Aventis U.S. LLC
Package NDC
58468-0123-1
Dosage Form
Injection
Presentation
Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1)
Initial Posting
12/10/2025
Revised Date

FDA data resources